Michael Bretherton is the chief executive officer of Sarossa Plc and is chairman of Adams Plc and a non- executive director of e-therapeutics plc. In addition, Michael is a director of Blake Holdings Limited and Ora Limited and has been a director of seven other AIM quoted companies during the last ten years, including DeepMatter Group Plc, Nanoco Group Plc, Ceres Power Holdings Plc and Tissue Regenix Group Plc.
Michael holds a degree in Economics from Leeds University and is a member of the Institute of Chartered Accountants in England and Wales. His early career included working as an accountant and manager with PriceWaterhouse for seven years in London and the Middle East.